Publications found:
36,694
Sort by:
3D Cell Culture Market by Scaffold Format (Scaffold Based and Scaffold Free System), Products (Hydrogel / Extracellular Matrix (ECM), 3D Bioreactor, 3D Petri Dish, Hanging Drop Plate, Microfluidic System, Micropatterned Surface, Microcarrier, Solid Scaffold, and Suspension System), Application Areas (Cancer Research, Drug Discovery and Toxicology, Stem Cell Research, Tissue Engineering and Regenerative Medicine), Purpose (Research Use and Therapeutic Use), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts (4th Edition), 2022-2035
US$ 4,799.00
The 3D cell culture market is expected to reach USD 1.2 billion by 2022 anticipated to grow at a CAGR of 16.7% during the forecast period 2022-2035. For a long time, animal testing has been a primary...
April 2022
481 pages
Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized (Antibodies, Cell and Gene Therapies, Vaccines and Other Biologics), Type of Primary Packaging System (Vials, Syringes, Cartridges, Ampoules and Others) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The lyophilization services market is expected to reach USD 2.2 billion in 2022 anticipated to grow at a CAGR of 6.8% during the forecast period 2022-2035. Over the past decade, there has been a consi...
April 2022
225 pages
Coronary Drug Eluting Stent Market - Distribution by Type of Drug Eluted (Sirolimus, Paclitaxel, Everolimus, Zotarolimus and Others), Stent Material (Platinum Chromium, Cobalt Chromium, Stainless Steel and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The coronary drug eluting stent market is currently valued at $3.8 billion in 2022 and is anticipated to experience a compounded annual growth rate (CAGR) of 9.26% throughout the forecast period. Card...
April 2022
254 pages
Viral Vaccine Cell Culture Media Market Distribution by Type of Cell Culture (Adherent and Suspension), Type of Media (Animal Component Free, Protein Free and Serum Free), Scale of Operation (Clinical Operations and Commercial Operations), Type of End-User (Industry Players and Non-Industry Players), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The viral vaccine cell culture market is expected to reach USD 1.6 billion in 2022 anticipated to grow at a CAGR of 5.8% during the forecast period 2022-2035. In recent years, there has been a signifi...
March 2022
180 pages
2021 Pharmaceuticals Research Review
US$ 3,000.00
... the growth of the pharmaceutical market. The approval of second CAR T-cell therapy tisagenlecleucel (Kymriah) in 2018 signifies the dramatic progress ... in the field. Pharmaceutical sector witnessed uncertainties due to the US ...
March 2022
299 pages
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2022
US$ 3,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2019 The ...
March 2022
100 pages
Myasthenia Gravis - Pipeline Insight, 2022
US$ 2,000.00
... clients within 48 Hours 'Myasthenia Gravis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Myasthenia Gravis development. The report provides ...
March 2022
60 pages
Asthma - Pipeline Insight, 2022
US$ 3,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Asthma - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in...
March 2022
100 pages
Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25...
March 2022
60 pages
Cystic Fibrosis - Pipeline Insight, 2022
US$ 3,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Cystic Fibrosis - Pipeline Insight, 2022,” report provides comprehensive insights about 75+ companies and 80+ pipeline dr...
March 2022
100 pages
Dravet Syndrome - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Dravet Syndrome - Pipeline Insight, 2022,” report provides comprehensive insights about 15+ companies and 15+ pipeline...
March 2022
50 pages
RIPK1 inhibitor - Pipeline Insights, 2022
US$ 1,500.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “RIPK1 inhibitors – Pipeline Insight, 2022,” report provides comprehensive insights about 10+ companies and 12+ pipeline d...
March 2022
50 pages
Glioblastoma - Pipeline Insight, 2022
US$ 3,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Glioblastoma - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline dru...
March 2022
100 pages
AXL kinase inhibitors - Pipeline Insights, 2022
US$ 2,000.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “AXL kinase inhibitors – Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pi...
March 2022
60 pages
Herpes Zoster - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Herpes Zoster – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline d...
March 2022
50 pages
iPSC derived NK cells - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “IPSCs derived NK cells – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 30+ pipe...
March 2022
60 pages
Malignant Pleural Mesothelioma- Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Malignant Pleural Mesothelioma- Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies an...
March 2022
60 pages
Metastatic Colorectal cancer - Pipeline Insight, 2022
US$ 5,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Metastatic Colorectal cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 140+ companies and 1...
March 2022
200 pages
Natural Killer (NK) cell therapy - Pipeline Insight, 2022
US$ 5,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Natural Killer (NK) cell therapy – Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies a...
March 2022
200 pages
Sezary Syndrome - Pipeline Insghts, 2022
US$ 1,250.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Sezary syndrome – Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drug...
March 2022
40 pages
Type2 Diabetes Mellitus- Pipeline Insight, 2022
US$ 3,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Type2 Diabetes Mellitus- Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pi...
March 2022
100 pages
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Beta Nerve Growth Factor (Beta NG...
February 2022
50 pages
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipelin...
February 2022
80 pages
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide D...
February 2022
74 pages
Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fatigue...
February 2022
36 pages
Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare d...
February 2022
75 pages
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipelin...
February 2022
59 pages
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 202...
February 2022
42 pages
Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipel...
February 2022
106 pages
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY H...
February 2022
29 pages
Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hy...
February 2022
33 pages
Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipe...
February 2022
37 pages
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key P...
February 2022
62 pages
Left Ventricular Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Left Ventricular Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease p...
February 2022
35 pages
Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease...
February 2022
39 pages
Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Noctur...
February 2022
32 pages
Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipelin...
February 2022
36 pages
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 20...
February 2022
44 pages
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gui...
February 2022
46 pages
Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Transforming Growth Factor Beta 1...
February 2022
112 pages
Venous Leg Ulcers (Crural ulcer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Venous Leg Ulcers (Crural ulcer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disea...
February 2022
60 pages
Global Antipsychotic Drugs Market 2021-2027
US$ 2,240.00
Antipsychotic drugs, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorder...
February 2022
76 pages
